Trials / Completed
CompletedNCT05215782
Eye to Brain Connection
Evaluation of Optina Retina Scans to Detect the Likeley Cerebral Amyloid Status (CAS) as Determined by Prospective PET Imaging
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 65 (actual)
- Sponsor
- Optina Diagnostics Inc. · Industry
- Sex
- All
- Age
- 50 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-randomized, non-treatment, observational study designed to discover correlations between retinal imaging and amyloid PET imaging. Subjects will be recruited to the clinical cohort from referring physicians. Subjects may be participants from existing studies and clinical practices
Conditions
Timeline
- Start date
- 2022-03-14
- Primary completion
- 2023-03-16
- Completion
- 2023-03-16
- First posted
- 2022-01-31
- Last updated
- 2023-03-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05215782. Inclusion in this directory is not an endorsement.